Where:
Sheraton Boston Hotel
39 Dalton Street
Boston, MA 02199
Admission:
$2699
Categories:
Business
Event website:
http://go.evvnt.com/88938-0
Gene Therapy for Rare Disorders 2017 is the only conference devoted to overcoming the clinical, manufacturing, regulatory and commercialization challenges holding back progress in this field.
Bringing together leading experts from innovative biotechs, large pharma, academia, regulatory authorities and key service provider companies, this conference will provide a comprehensive insight into the cutting edge progress of gene therapies combatting rare disease.
Rather than replicating broad academic cell and gene therapy meetings, you will learn from in-depth case studies detailing how gene therapies can become commercially successful in ophthalmic, CNS, hepatic, muscular and many other rare disorders.
Join your colleagues on this collaborative platform to accelerate the progress of the next generation of gene therapies that show improved efficacy, enhanced safety and commercial viability.
Urls:
Brochure: https://go.evvnt.com/88938-1
Booking: https://go.evvnt.com/88938-2
Prices:
Conference : USD 2699
Conference - Early Bird Price: USD 2599
Speakers: Michael Linden (VP, Gene Therapy, Pfizer), Lei Xu (Chief General Medicine Branch 2, Division of Clinical Evaluation and Pharmacology/Toxicology, OTAT, CBER, FDA), Lance Weed (VP, US Operations, UniQure), Seng Cheng (Global Head of Research, Rare Diseases, Sanofi), Sam Wadsworth (CSO, Dimension Therapeutics)
Category: Conferences | Science, Health and Medicine | Pharmaceuticals | Drug Development
Saturday, Dec 21, 2024 7:30p
Boston Harbor Distillery
Saturday, Dec 21, 2024 11:00a
Crystal Ballroom at Somerville Theatre
Sunday, Dec 22, 2024 11:00a
Roadrunner Boston
Thursday, Dec 19, 2024 4:00p
Crystal Ballroom at Somerville Theatre